Busch Andreas 4
4 · Cyclerion Therapeutics, Inc. · Filed Nov 12, 2020
Insider Transaction Report
Form 4
Busch Andreas
Chief Innovation Officer
Transactions
- Purchase
Common Stock
2020-11-09$2.53/sh+125,000$316,250→ 254,704 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.60, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.
- [F2]The reporting person acquired 2,204 and 2,500 shares of Common Stock under the issuer's employee stock purchase plan on November 29, 2019 and May 29, 2020, respectively.